TG Therapeutics TGTX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $442.21M+235% | $79.15M-56.0% | $74.08M-62.2% | $129.13M+55.7% | $132.14M+75.1% | ||
| $1.19B+130% | $992.65M+152% | $816.21M+159% | $666.55M+179% | $518.64M+200% | ||
| $344.19M+6.3% | $475.6M+95.2% | $459.91M+62.3% | $397.63M+71.1% | $323.67M+78.5% | ||
| $1.09B+68.7% | $630.76M+11.4% | $599.77M+4.5% | $663.96M+70.6% | $644.51M+78.7% | ||
| $72.22M-49.9% | $62.82M-52.1% | $57.5M-60.4% | $122.74M-8.6% | $144.1M— | ||
| $1.53B+133% | $1.06B+84.1% | $1.03B+74.9% | $702.61M+75.1% | $656.69M+75.9% | ||
| $148.85M+11.1% | $107.51M+84.4% | $112.34M+10.8% | $134.02M+43.4% | $133.93M+53.5% | ||
| $6.86M+4.0% | $8.81M-27.1% | $8.35M-48.4% | $1.67M-55.5% | $6.6M+103% | ||
| $187.11M+16.8% | $153.76M+69.6% | $156.81M+25.3% | $171.89M+58.2% | $160.21M+60.7% | ||
| $745.14M+204% | $245.65M+0.5% | $245.34M+0.5% | $245.04M+139% | $244.73M+142% | ||
| $945.71M+125% | $415.23M+16.9% | $417.81M+6.1% | $426.18M+90.6% | $419.4M+96.7% | ||
| $160K+0.6% | $159K+1.9% | $159K+1.9% | $159K+2.6% | $159K+2.6% | ||
| -$1.06B+30.3% | -$1.08B+29.2% | -$1.11B+28.8% | -$1.5B+3.9% | -$1.52B+0.1% | ||
| $583.13M+146% | $648.02M+191% | $607.22M+216% | $276.43M+55.7% | $237.29M+48.2% | ||
| $1.53B+133% | $1.06B+84.1% | $1.03B+74.9% | $702.61M+75.1% | $656.69M+75.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TG Therapeutics's total assets?
- TG Therapeutics (TGTX) holds $1.5B in total assets, up 132.8% year over year.
- How much debt does TG Therapeutics have?
- TG Therapeutics carries $753.6M in total debt against $583.1M of shareholders' equity, a debt-to-equity ratio of 1.29.
- How much cash does TG Therapeutics have?
- TG Therapeutics holds $442.2M in cash and equivalents.
- Can TG Therapeutics cover its short-term obligations?
- Its current ratio is 5.81 — current assets exceed current liabilities.
- Where does TG Therapeutics's balance sheet data come from?
- Every line is extracted from TG Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
